AGP Picks View all

Daily Tech News Seychelles: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Daily Tech News Seychelles.

Press releases published on September 8, 2026

MediciNova to Participate in Two Investor Conferences in September
SLC Digital Launches New Platform to Bring Hardware-Rooted Transaction Assurance to the AI Era
Pulmovant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study
Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026
Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1
Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study
Frank D. “Trey” Whitworth, Former Director of the NGA, Appointed as President of Satellogic
Aico by Pacera Achieves SAP®-certified for Clean Core with RISE with SAP
Orikine appoints new CEO and Leadership Team to advance ORK1 in Autoimmune Disease
Proofpoint Strengthens Executive Leadership Team with Appointment of Chief Legal Officer and Chief People Officer
Autheo Brings THEO to Robinhood Chain as Two Visions of Convergence Meet
Timo, an In-Car AI Social Robot, Is Coming to Kickstarter to Make Everyday Drives More Interactive and Fun
Prophecy Launches AI Data Prep Tools to Close the Gap Between AI Investment and AI Results
Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026
PannTheraPi Receives ANSM Approval to Advance PTI5803 into Phase 2a in Focal Cortical Dysplasia
Cytospire Therapeutics Appoints Highly Experienced Immuno-Oncology Leader, Sumeet Ambarkhane, M.D., as Chief Medical Officer
PannTheraPi obtient l'approbation de l’ANSM pour l’entrée en Phase 2a de PTI5803 dans la dysplasie corticale focale
Magnite Launches First Agentic Campaign in EMEA With Amnet France
Greywolf Therapeutics doses first participants with axSpA in novel ERAP1 inhibitor trial
Consecutive Profitable Quarters in Second Half of Fiscal 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Daily Tech News Seychelles

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.